Stay updated with breaking news from Immunity Task Force. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
COVID-19 antibodies wane much faster than expected among seniors and those with comorbidities, according to the latest research on long-term care residents funded by the COVID-19 Immunity Task Force -- findings they say reinforce policy decisions and recommendations around providing booster shots to vulnerable populations.
Scientists with the Ajmera Transplant Centre at UHN have conducted a first-in-the-world randomized placebo-controlled trial of third dose COVID-19 booster vaccine for transplant patients that shows substantially improved protection. “We knew from previous studies, that two doses were not enough to produce a good immune response against COVID-19 in transplant patients,” says Dr. Deepali Kumar, […]
MONTREAL, Oct. 05, 2021 -- The Government of Canada, through the COVID-19 Immunity Task Force , is supporting a study that will investigate COVID-19 among the Orthodox Jewish community in...
MONTREAL, Oct. 05, 2021 (GLOBE NEWSWIRE) -- The Government of Canada, through the COVID-19 Immunity Task Force (CITF), is supporting a study that will...
The COVID-19 pandemic has had a unique effect on Orthodox Jewish communities, and a new study aims to find out more and hopes the results will prove useful to direct policy in many of Canada's marginalized communities.